Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-19-002344
Filing Date
2019-08-27
Accepted
2019-08-27 15:39:59
Documents
1
Period of Report
2019-08-22

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312274noh_08272019.html 3  
1 OWNERSHIP DOCUMENT form312274noh_08272019.xml 3 3025
  Complete submission text file 0000921895-19-002344.txt   4414
Mailing Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER 47TH FLOOR NEW YORK NY 10007 646-975-2500
PROGENICS PHARMACEUTICALS INC (Issuer) CIK: 0000835887 (see all company filings)

EIN.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055 POWERS PLACE, SUITE B ALPHARETTA GA 30009
Business Address
Nohria Virinder (Reporting) CIK: 0001619077 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23143 | Film No.: 191057173